Early identification of risk factors and diagnosis of metabolic syndrome in overweight and obese children above 6 years of age


  • Minakshi B. Department of Pediatrics, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, India
  • Chithambaram N. S. Department of Pediatrics, Vydehi Institute of Medical Sciences and Research Centre, Bangalore, India




Metabolic syndrome, Obesity, Overweight


Background: Metabolic syndrome is a complex disorder and an emerging clinical challenge all over the world. It is considered a multiplex cardiovascular risk factor, in that each component of the cluster of abnormalities is a risk factor in its own right. The objective of the study was to identify the risk factors and diagnose metabolic syndrome early in overweight and obese children.

Methods: The observational study was conducted at the Vydehi Institute of Medical Sciences and Research Centre, Bangalore. Total 100 children who were overweight and obese were participated. The outcome measure of the study was considered as metabolic syndrome. In patients above 6 years who are overweight and obese, a detailed history including antenatal history, birth weight, diet history, personal history was taken. In these patient’s demographic details, anthropometric measurements weight, height, BMI, waist circumference, waist hip ratio and blood pressure were recorded. FBS, triglyceride and HDL were also done.

Results: Out of 100 children studied, 61% were overweight and 39% were obese. Males were 52% and females were 48%. 92 were AGA, 6 were SGA and 2 were LGA .92% had normal FBS and 8% had high levels of FBS .85% had normal TGL and 15% more than 150mg/dl. 69% had HDL-C less than 40 mg/dl and 31% had HDL-C more than or equal to 40mg/dl. Out of 8 cases of MS, 3 had abnormal FBS and HDL-C, 2 cases had abnormal TGL and HDL-C, and 3 cases abnormal FBS, TGL and HDL-C. In the remaining 92 cases, only one metabolic abnormality was noticed in 73 cases (abnormal FBS- 2, abnormal TGL-10 and abnormal HDL-C in 61) and in remaining 19 cases none of the risk factors for MS were detected.

Conclusions: By identifying these risk factors early in overweight and obese children, we can identify metabolic syndrome early and initiate necessary treatment and prevent the complications of MS.


Kylin E. Studies on the Hypertension Hyperglyca 'mie-Hyperurica' miesyndrom. Zentralbl Inn Med. 1923;44:105-27.

Vague J. Sexual differentiation, a determining factor in the forms of obesity. Presse Medl 1947;53:339-40.

Avogaro P, Crepaldi G. Essential hyperlipidemia, obesity and diabetes. Diabetologia. 1965;1:137.

Reaven GM. Banting lecture 1988. Role of insulin resistance in human disease. Diabetes. 1988;37:1595-607.

Kaplan NM. The deadly quartet. Upper-body obesity, glucose intolerance, hypertriglyceridemia, and hypertension. Arch Intern Med. 1989;149:1514-20.

Alberti KG, Zimmet P, Shaw J. Metabolic syndrome- a new world-wide definition. A Consensus Statement from the International Diabetes Federation. Diabet Med. 2006:23;469-80.

Pan WH, Yeh WT, Weng LC. Epidemiology of metabolic syndrome in Asia: Asia Pac J Clin Nutr. 200817Suppl 1:37-42.

Mohan V, Sandeep S, Deepa R, Shah B, Varghese C. Epidemiology of type 2 diabetes: Indian scenario. Indian J Medic Res. 2007;125(3):217-30.

Mohan V, Deepa R, Deepa M, Somannavar S, Datta M.A. Simplified Indian diabetes risk score for screening for undiagnosed diabetic subjects. J Assoc Physicians India. 2005;53:759-6.

Jaspinder Kaur. A comprehensive review on metabolic syndrome. Cardiol Res Pract. 2014:943162.

Gupta N, Shah P, Nayyar S, MisraA. Childhood obesity and the metabolic syndrome in developing countries. Indian J Pediatr. 2013;80Suppl 1:S28-37.

Hadjiyannakis S. The metabolic syndrome in children and adolescents. Paediatr Child Health. 2005;10(1):41-7.

Singh N, Parihar RK, Saini G, Mohan SK, Sharma N, Razaq M. Prevalence of metabolic syndrome in adolescents aged 10-18 years in Jammu, J and K. Indian J Endocrinol Metabol. 2013;17(1):133.

Rodrigues LG, Mattos AP, Koifman S. Prevalence of metabolic syndrome in overweight and obese outpatient children and adolescents: comparative analysis using different clinical definitions. Revista Paulista de Pediatria. 2011;29(2):178-85.

Hales CN, Barker DJP. Type 2 (non-insulin-dependent) diabetes mellitus: the thrifty phenotype hypothesis. Diabetologia. 1992;35:595-601.

Boney CM, Verma A, Tucker RV, Vohr BR. Metabolic syndrome in childhood: association with birth weight maternal obesity and gestational diabetes mellitus. Pediatr. 2005;115(3):e290-96.

Council on communications and media. AAP policy statement - children, adolescents, obesity, and the media. Pediatrics. 2011;128(1):201-8.

Guinhouya BC. Physical activity in preventing metabolic syndrome in children. Med Sci. 2009;25(10):827-33.

Wang X, Liang L, Junfen FU, Lizhong DU. Metabolic syndrome in obese children born large for gestational age. Indian J Pediatr. 2007;74(6):561.

Andrabi SM, Bhat MH, Andrabi SR, Kamili MM, Imran A, Nisar I, et al. Prevalence of metabolic syndrome in 8-18-year-old school-going children of Srinagar city of Kashmir India. Indian J Endocrinol Metabo. 2013;17(1):95.

Grundy SM, Howard B, Smith S, Eckel R, Redberg R, Bonow RO. Diabetes and cardiovascular disease executive summary conference proceeding for healthcare professionals from a special writing group of the American Heart Association. Circulation. 2002;105:2231-9.

Bhat RA, Paray I, Zargar S, Ganie A, Khan I. Prevalence of the metabolic syndrome among north Indian adolescents using adult treatment panel III and pediatric international diabetic federation definitions. Arch Med Health Sci. 2015;3(1):44-9.

Bhalavi V, Deshmukh PR, Goswami K, Garg N. Prevalence and correlates of metabolic syndrome in the adolescents of rural Wardha. Indian J Community Med. 2015;40(1):43-8.

Williams L. Third report of the National Cholesterol Education Program (NCEP) expert panel on detection, evaluation, and treatment of high blood cholesterol in adults (Adult Treatment Panel III) final report. Circulation. 2002;106(25):3143.

Liu X, Tao L, Cao K, Wang Z, Chen D, Guo J, et al. Association of high-density lipoprotein with development of metabolic syndrome components: a five-year follow-up in adults. BMC Public Health. 2015;15(1):412.

Ridker PM, Buring JE, Cook NR, Rifai N. C-reactive protein, the metabolic syndrome, and risk of incident cardiovascular events. Circulation. 2003;107(3):391-7.

Reshma D, Suma MN, Srinath KM, Prashant V, Akila PC. Reactive Protein an inflammatory marker in Metabolic Syndrome. J Med Dent Sci Res. 2015;2(8):11-19.






Original Research Articles